Annual Cost Of Goods Sold
$4.66 M
-$1.93 M-29.31%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual cost of goods sold is currently $4.66 million, with the most recent change of -$1.93 million (-29.31%) on 31 December 2023. During the last 3 years, it has risen by +$2.98 million (+178.10%). BCRX annual cost of goods sold is now -35.83% below its all-time high of $7.26 million, reached on 31 December 2021.BCRX Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$3.23 M
+$1.49 M+86.16%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly cost of goods sold is currently $3.23 million, with the most recent change of +$1.49 million (+86.16%) on 30 September 2024. Over the past year, it has increased by +$2.09 million (+184.15%). BCRX quarterly cost of goods sold is now -53.22% below its all-time high of $6.90 million, reached on 31 December 1995.BCRX Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$7.99 M
+$2.09 M+35.46%
30 September 2024
Summary:
BioCryst Pharmaceuticals TTM cost of goods sold is currently $7.99 million, with the most recent change of +$2.09 million (+35.46%) on 30 September 2024. Over the past year, it has increased by +$2.47 million (+44.76%). BCRX TTM cost of goods sold is now -0.08% below its all-time high of $8.00 million, reached on 30 June 2023.BCRX TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.3% | +184.2% | +44.8% |
| 3 y3 years | +178.1% | +424.9% | +14.8% |
| 5 y5 years | +889.6% | +10000.0% | +399.4% |
BCRX Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -35.8% | +178.1% | -10.7% | +1256.3% | -0.1% | +426.1% |
| 5 y | 5 years | -35.8% | +889.6% | -45.5% | >+9999.0% | -0.1% | +426.1% |
| alltime | all time | -35.8% | +876.8% | -53.2% | +1176.0% | -0.1% | +1241.6% |
BioCryst Pharmaceuticals Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.23 M(+86.2%) | $7.99 M(+35.5%) |
| June 2024 | - | $1.73 M(+24.6%) | $5.90 M(+15.3%) |
| Mar 2024 | - | $1.39 M(-15.0%) | $5.12 M(+9.7%) |
| Dec 2023 | $4.66 M(-29.3%) | $1.64 M(+44.1%) | $4.66 M(-15.6%) |
| Sept 2023 | - | $1.14 M(+19.6%) | $5.52 M(-31.0%) |
| June 2023 | - | $950.00 K(+1.3%) | $8.00 M(+9.6%) |
| Mar 2023 | - | $938.00 K(-62.4%) | $7.29 M(+10.6%) |
| Dec 2022 | $6.59 M(-9.2%) | $2.50 M(-30.9%) | $6.59 M(+46.0%) |
| Sept 2022 | - | $3.61 M(+1362.8%) | $4.52 M(+197.4%) |
| June 2022 | - | $247.00 K(+3.8%) | $1.52 M(-5.9%) |
| Mar 2022 | - | $238.00 K(-43.2%) | $1.61 M(-77.9%) |
| Dec 2021 | $7.26 M(+333.4%) | $419.00 K(-31.9%) | $7.30 M(+4.9%) |
| Sept 2021 | - | $615.00 K(+79.3%) | $6.96 M(-11.6%) |
| June 2021 | - | $343.00 K(-94.2%) | $7.87 M(+4.6%) |
| Mar 2021 | - | $5.92 M(+7212.3%) | $7.53 M(+349.3%) |
| Dec 2020 | $1.68 M(-59.1%) | $81.00 K(-94.7%) | $1.68 M(-59.8%) |
| Sept 2020 | - | $1.53 M(+2111.6%) | $4.17 M(+55.2%) |
| Mar 2020 | - | $69.00 K(-97.3%) | $2.68 M(-34.6%) |
| Dec 2019 | $4.10 M(+770.7%) | $2.57 M(>+9900.0%) | $4.10 M(+156.3%) |
| Sept 2019 | - | $18.00 K(-30.8%) | $1.60 M(0.0%) |
| June 2019 | - | $26.00 K(-98.3%) | $1.60 M(-11.9%) |
| Mar 2019 | - | $1.49 M(+2022.9%) | $1.82 M(+285.8%) |
| Dec 2018 | $471.00 K(-72.3%) | $70.00 K(+288.9%) | $471.00 K(-11.1%) |
| Sept 2018 | - | $18.00 K(-92.6%) | $530.00 K(-70.0%) |
| June 2018 | - | $243.00 K(+73.6%) | $1.77 M(+14.3%) |
| Mar 2018 | - | $140.00 K(+8.5%) | $1.55 M(-9.0%) |
| Dec 2017 | $1.70 M(-36.9%) | $129.00 K(-89.7%) | $1.70 M(-57.7%) |
| Sept 2017 | - | $1.26 M(+5613.6%) | $4.03 M(+38.3%) |
| June 2017 | - | $22.00 K(-92.5%) | $2.91 M(-0.2%) |
| Mar 2017 | - | $294.00 K(-88.0%) | $2.92 M(+8.0%) |
| Dec 2016 | $2.70 M(+42.4%) | $2.45 M(+1614.7%) | $2.70 M(+881.5%) |
| Sept 2016 | - | $143.00 K(+429.6%) | $275.00 K(-81.5%) |
| June 2016 | - | $27.00 K(-64.9%) | $1.48 M(-21.9%) |
| Mar 2016 | - | $77.00 K(+175.0%) | $1.90 M(+0.1%) |
| Dec 2015 | $1.90 M | $28.00 K(-97.9%) | $1.90 M(-0.8%) |
| Sept 2015 | - | $1.35 M(+205.7%) | $1.91 M(+240.8%) |
| June 2015 | - | $442.00 K(+489.3%) | $561.00 K(+352.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $75.00 K(+70.5%) | $124.00 K(+1.6%) |
| Dec 2014 | $122.00 K(+24.5%) | $44.00 K(+780.0%) | $122.00 K(+28.4%) |
| June 2014 | - | $5000.00(-93.2%) | $95.00 K(+1.1%) |
| Mar 2014 | - | $73.00 K(+329.4%) | $94.00 K(-4.1%) |
| Dec 2013 | $98.00 K(-25.8%) | $17.00 K(+325.0%) | $98.00 K(-54.0%) |
| June 2013 | - | $4000.00(-94.8%) | $213.00 K(+1.9%) |
| Mar 2013 | - | $77.00 K(+327.8%) | $209.00 K(+58.3%) |
| Dec 2012 | $132.00 K(+53.5%) | $18.00 K(-84.2%) | $132.00 K(+15.8%) |
| Sept 2012 | - | $114.00 K(+32.6%) | $114.00 K(-97.5%) |
| Dec 2010 | $86.00 K(-98.1%) | - | - |
| Mar 2010 | - | $86.00 K(-98.1%) | $4.63 M(+1.9%) |
| Dec 2009 | $4.54 M(-1008.8%) | $4.54 M(-3031.5%) | $4.54 M(-918.7%) |
| Mar 2000 | - | -$155.00 K(+55.0%) | -$555.00 K(+11.0%) |
| Dec 1999 | -$500.00 K(0.0%) | -$100.00 K(0.0%) | -$500.00 K(0.0%) |
| Sept 1999 | - | -$100.00 K(-50.0%) | -$500.00 K(0.0%) |
| June 1999 | - | -$200.00 K(+100.0%) | -$500.00 K(-16.7%) |
| Mar 1999 | - | -$100.00 K(0.0%) | -$600.00 K(0.0%) |
| Dec 1998 | -$500.00 K(-16.7%) | -$100.00 K(0.0%) | -$600.00 K(0.0%) |
| Sept 1998 | - | -$100.00 K(-66.7%) | -$600.00 K(-14.3%) |
| June 1998 | - | -$300.00 K(+200.0%) | -$700.00 K(+16.7%) |
| Mar 1998 | - | -$100.00 K(0.0%) | -$600.00 K(-126.1%) |
| Dec 1997 | -$600.00 K(+20.0%) | -$100.00 K(-50.0%) | $2.30 M(0.0%) |
| Sept 1997 | - | -$200.00 K(0.0%) | $2.30 M(-4.2%) |
| June 1997 | - | -$200.00 K(-107.1%) | $2.40 M(0.0%) |
| Mar 1997 | - | $2.80 M(-2900.0%) | $2.40 M(-580.0%) |
| Dec 1996 | -$500.00 K(-107.7%) | -$100.00 K(0.0%) | -$500.00 K(-107.7%) |
| Sept 1996 | - | -$100.00 K(-50.0%) | $6.50 M(0.0%) |
| June 1996 | - | -$200.00 K(+100.0%) | $6.50 M(-1.5%) |
| Mar 1996 | - | -$100.00 K(-101.4%) | $6.60 M(+1.5%) |
| Dec 1995 | $6.50 M(+30.0%) | $6.90 M(-7000.0%) | $6.50 M(+441.7%) |
| Sept 1995 | - | -$100.00 K(0.0%) | $1.20 M(-53.8%) |
| June 1995 | - | -$100.00 K(-50.0%) | $2.60 M(-33.3%) |
| Mar 1995 | - | -$200.00 K(-112.5%) | $3.90 M(-22.0%) |
| Dec 1994 | $5.00 M | $1.60 M(+23.1%) | $5.00 M(+47.1%) |
| Sept 1994 | - | $1.30 M(+8.3%) | $3.40 M(+61.9%) |
| June 1994 | - | $1.20 M(+33.3%) | $2.10 M(+133.3%) |
| Mar 1994 | - | $900.00 K | $900.00 K |
FAQ
- What is BioCryst Pharmaceuticals annual cost of goods sold?
- What is the all time high annual cost of goods sold for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual cost of goods sold year-on-year change?
- What is BioCryst Pharmaceuticals quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly cost of goods sold year-on-year change?
- What is BioCryst Pharmaceuticals TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM cost of goods sold year-on-year change?
What is BioCryst Pharmaceuticals annual cost of goods sold?
The current annual cost of goods sold of BCRX is $4.66 M
What is the all time high annual cost of goods sold for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual cost of goods sold is $7.26 M
What is BioCryst Pharmaceuticals annual cost of goods sold year-on-year change?
Over the past year, BCRX annual cost of goods sold has changed by -$1.93 M (-29.31%)
What is BioCryst Pharmaceuticals quarterly cost of goods sold?
The current quarterly cost of goods sold of BCRX is $3.23 M
What is the all time high quarterly cost of goods sold for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly cost of goods sold is $6.90 M
What is BioCryst Pharmaceuticals quarterly cost of goods sold year-on-year change?
Over the past year, BCRX quarterly cost of goods sold has changed by +$2.09 M (+184.15%)
What is BioCryst Pharmaceuticals TTM cost of goods sold?
The current TTM cost of goods sold of BCRX is $7.99 M
What is the all time high TTM cost of goods sold for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM cost of goods sold is $8.00 M
What is BioCryst Pharmaceuticals TTM cost of goods sold year-on-year change?
Over the past year, BCRX TTM cost of goods sold has changed by +$2.47 M (+44.76%)